Ellington Management Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-11,300
Closed -$247K 522
2019
Q3
$247K Sell
11,300
-12,600
-53% -$288K 0.04% 428
2019
Q2
$603K Buy
+23,900
New +$567K 0.1% 194
2017
Q3
Sell
-63,700
Closed -$1.1M 639
2017
Q2
$1.1M Sell
63,700
-37,500
-37% -$450K 0.16% 69
2017
Q1
$1.12M Buy
+101,200
New +$1.39M 0.04% 70
2015
Q3
Sell
-1,900
Closed -$422K 713
2015
Q2
$422K Buy
+1,900
New +$421K 0.1% 303

Other funds holding BHC

Ellington Management Group's BHC Position: Q4 2019 in Review

Ellington Management Group sold out of Bausch Health (BHC) in Q4 2019, closing a stake of 11,300 shares — an estimated $247K sold.

Ellington Management Group first reported a position in BHC in Q2 2015 and held it in 5 quarters. The position peaked at $1.12M in Q1 2017. 327 funds tracked by Wall St. Rank hold BHC as of Q4 2019.

  • Ellington Management Group reported no remaining Bausch Health position as of Q4 2019 after selling out during the quarter.
  • Ellington Management Group sold 11,300 Bausch Health shares in Q4 2019, an estimated $247K.
  • Ellington Management Group first reported a position in Bausch Health in Q2 2015 and held it in 5 quarters.
  • Ellington Management Group's Bausch Health position peaked at $1.12M in Q1 2017.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q4 2019.

Based on Ellington Management Group's 13F filing for Q4 2019, filed 14 Feb 2020.